Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Shares Outstanding (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 3 years of Shares Outstanding data on record, last reported at $123.7 million in Q2 2022.

  • For Q2 2022, Shares Outstanding fell 13.7% year-over-year to $123.7 million; the TTM value through Jun 2022 reached $123.7 million, down 13.7%, while the annual FY2021 figure was $123.7 million, 23.17% down from the prior year.
  • Shares Outstanding reached $131.5 million in Q2 2022 per MRVI's latest filing, up from $123.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $161.0 million in Q4 2020 and bottomed at $123.7 million in Q4 2021.
  • Average Shares Outstanding over 3 years is $139.4 million, with a median of $131.5 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding: rose 27.96% in 2021, then dropped 23.17% in 2022.
  • A 3-year view of Shares Outstanding shows it stood at $96.6 million in 2020, then grew by 27.96% to $123.7 million in 2021, then changed by 0.0% to $123.7 million in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $123.7 million in Q2 2022, $123.7 million in Q1 2022, and $123.7 million in Q4 2021.